CLRB - 2.28 Pre-market now at 2.48/2.50 CLR 131 Achieves 50% Overall Response Rate in Cohort 6 of Ongoing Phase 1 Study in Relapsed or Refractory Multiple Myeloma https://www.tradescores.com/StockReport/clrb